Lack of efficacy of infliximab in the treatment of primary sclerosing cholangitis in inflammatory bowel diseases in childhood.

Authors :: Cardile S
Candusso M
Papadatou B
Bracci F
Knafelz D
Torre G
Source :: European journal of gastroenterology & hepatology [Eur J Gastroenterol Hepatol] 2017 Jun; Vol. 29 (6), pp. 736.
Publication Year :: 2017

Subjects :: Adolescent
Anti-Inflammatory Agents adverse effects
Cholangitis, Sclerosing diagnosis
Cholangitis, Sclerosing immunology
Colitis, Ulcerative diagnosis
Colitis, Ulcerative immunology
Female
Gastrointestinal Agents adverse effects
Humans
Infliximab adverse effects
Male
Retrospective Studies
Treatment Outcome
Anti-Inflammatory Agents therapeutic use
Cholangitis, Sclerosing drug therapy
Colitis, Ulcerative drug therapy
Gastrointestinal Agents therapeutic use
Infliximab therapeutic use

Full Text Access

Tools